{"id":"https://openalex.org/W1762532995","doi":"https://doi.org/10.1093/annonc/mdu344.20","title":"Predictors of Treatment (Tx) Response and Progression in Braf V600E Metastatic Melanoma (Mm) Patients (Pts) with Brain Metastases (Bm) Receiving Vemurafenib (Vem) in a Real-World Setting","display_name":"Predictors of Treatment (Tx) Response and Progression in Braf V600E Metastatic Melanoma (Mm) Patients (Pts) with Brain Metastases (Bm) Receiving Vemurafenib (Vem) in a Real-World Setting","publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W1762532995","doi":"https://doi.org/10.1093/annonc/mdu344.20","mag":"1762532995"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdu344.20","doi":"https://doi.org/10.1093/annonc/mdu344.20","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdu344.20","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1093/annonc/mdu344.20","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026672076","display_name":"Geoffrey Thomas Gibney","orcid":"https://orcid.org/0000-0002-5401-8498","observed_orcids":["https://orcid.org/0000-0002-5401-8498"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Gibney","raw_affiliation_strings":["Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039045250","display_name":"Genevi\u00e8ve Gauthier","orcid":"https://orcid.org/0000-0001-6098-0790","observed_orcids":["https://orcid.org/0000-0001-6098-0790"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Gauthier","raw_affiliation_strings":["HEOR, Analysis Group, Montreal, QC, CANADA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HEOR, Analysis Group, Montreal, QC, CANADA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030064260","display_name":"Charles Ayas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Ayas","raw_affiliation_strings":["HEOR, Analysis Group, Montreal, QC, CANADA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HEOR, Analysis Group, Montreal, QC, CANADA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033612438","display_name":"Philip Galebach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Galebach","raw_affiliation_strings":["HEOR, Analysis Group, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HEOR, Analysis Group, Boston, MA, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103268197","display_name":"E.Q. Wu","orcid":"https://orcid.org/0000-0002-7951-6485","observed_orcids":["https://orcid.org/0000-0002-7951-6485"]},"institutions":[{"id":"https://openalex.org/I79463011","display_name":"Analysis Group (United States)","ror":"https://ror.org/044jp1563","country_code":"US","type":"company","lineage":["https://openalex.org/I79463011"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Wu","raw_affiliation_strings":["HEOR, Analysis Group, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HEOR, Analysis Group, Boston, MA, USA","institution_ids":["https://openalex.org/I79463011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113565722","display_name":"Yeun Mi Yim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y.M. Yim","raw_affiliation_strings":["Health Economics and Outcomes Research, Genentech Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, Genentech Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072081357","display_name":"Sarang S. Abhyankar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.S. Abhyankar","raw_affiliation_strings":["Health Economics and Outcomes Research, Genentech Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, Genentech Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057312624","display_name":"Carolina M. Reyes","orcid":"https://orcid.org/0000-0002-6358-3464","observed_orcids":["https://orcid.org/0000-0002-6358-3464"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Reyes","raw_affiliation_strings":["Health Economics and Outcomes Research, Genentech Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, Genentech Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109084559","display_name":"A. Gu\u00e9rin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Guerin","raw_affiliation_strings":["HEOR, Analysis Group, Montreal, QC, CANADA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HEOR, Analysis Group, Montreal, QC, CANADA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.05725018,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":null,"first_page":"iv382","last_page":"iv382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.5054000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.5054000020027161,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.44429999589920044,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.8489999771118164},{"id":"https://openalex.org/keywords/brain-metastases","display_name":"brain metastases","score":0.9369999766349792},{"id":"https://openalex.org/keywords/braf-v600e-mutation","display_name":"BRAF V600E mutation","score":0.9480000138282776},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":1.0},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.8550000190734863},{"id":"https://openalex.org/keywords/intracranial-response","display_name":"intracranial response","score":0.8220000267028809},{"id":"https://openalex.org/keywords/intracranial-progression","display_name":"intracranial progression","score":0.984000027179718},{"id":"https://openalex.org/keywords/predictors-of-treatment-response","display_name":"predictors of treatment response","score":0.8320000171661377},{"id":"https://openalex.org/keywords/corticosteroid-use","display_name":"corticosteroid use","score":0.9539999961853027},{"id":"https://openalex.org/keywords/extracranial-disease","display_name":"extracranial disease","score":0.675000011920929},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6510000228881836},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6169999837875366},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.925000011920929},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.45500001311302185},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9702543020248413},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9306982755661011},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.7023400664329529},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6329526305198669},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5986806750297546},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5672507882118225},{"id":"https://openalex.org/C2778164965","wikidata":"https://www.wikidata.org/wiki/Q1620196","display_name":"Brain metastasis","level":4,"score":0.45822465419769287},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35827237367630005},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.25306954979896545},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.15654537081718445}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdu344.20","doi":"https://doi.org/10.1093/annonc/mdu344.20","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdu344.20","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdu344.20","doi":"https://doi.org/10.1093/annonc/mdu344.20","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdu344.20","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2907066196","https://openalex.org/W1976861221","https://openalex.org/W2170839278","https://openalex.org/W2120280931","https://openalex.org/W2143222157","https://openalex.org/W2603611788","https://openalex.org/W2006741643","https://openalex.org/W2240794955","https://openalex.org/W2320148628","https://openalex.org/W2017048126"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}